Switch to
More onapp

How to use scorecard? Learn more

Ganga Pharmaceuticals Ltd

GANGAPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11 cr, stock is ranked 4,075
High RiskStock is 7.82x as volatile as Nifty
24.670.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Bad

The stock is in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹11 cr, stock is ranked 4,075
High RiskStock is 7.82x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
2.19
Dividend YieldDiv. Yield
Sector PESector PE
43.83
Sector PBSector PB
5.97
Sector Div YldSctr Div Yld
0.59%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ganga Pharmaceuticals is engaged in manufacturing and trading in pharmaceuticals and allied products.

Financial TrendFinancial statements 

20212022202320242.622.752.892.980.010.060.040.05
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 10.69%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnApr 11, 2024

Ganga Pharmaceuticals Ltd - 539680 - Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation, 2015 For The Year Ended On March 31, 2024 | Download

Ganga Pharmaceuticals Ltd - 539680 - Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation, 2015 For The Year Ended On March 31, 2024 | Download

See all events